Chen Mei-Hsiu, Liu Tse-Ying, Chen Yu-Chiao, Chen Ming-Hong
Department of Internal Medicine, Far Eastern Memorial Hospital, New Taipei 220, Taiwan.
Department of Biomedical Engineering, Ming Chuang University, Taoyuan 333, Taiwan.
Nanomaterials (Basel). 2021 Jun 24;11(7):1661. doi: 10.3390/nano11071661.
Glioblastoma, formerly known as glioblastoma multiforme (GBM), is refractory to existing adjuvant chemotherapy and radiotherapy. We successfully synthesized a complex, Au-OMV, with two specific nanoparticles: gold nanoparticles (AuNPs) and outer-membrane vesicles (OMVs) from . Au-OMV, when combined with radiotherapy, produced radiosensitizing and immuno-modulatory effects that successfully suppressed tumor growth in both subcutaneous G261 tumor-bearing and in situ (brain) tumor-bearing C57BL/6 mice. Longer survival was also noted with in situ tumor-bearing mice treated with Au-OMV and radiotherapy. The mechanisms for the successful treatment were evaluated. Intracellular reactive oxygen species (ROS) greatly increased in response to Au-OMV in combination with radiotherapy in G261 glioma cells. Furthermore, with a co-culture of G261 glioma cells and RAW 264.7 macrophages, we found that GL261 cell viability was related to chemotaxis of macrophages and TNF-α production.
胶质母细胞瘤,以前称为多形性胶质母细胞瘤(GBM),对现有的辅助化疗和放疗具有耐药性。我们成功合成了一种复合物Au-OMV,它由两种特定的纳米颗粒组成:金纳米颗粒(AuNPs)和来自[具体来源未提及]的外膜囊泡(OMV)。Au-OMV与放疗联合使用时,产生了放射增敏和免疫调节作用,成功抑制了皮下接种G261肿瘤的和原位(脑)接种肿瘤的C57BL/6小鼠的肿瘤生长。接受Au-OMV和放疗治疗的原位接种肿瘤小鼠的生存期也更长。对成功治疗的机制进行了评估。在G261胶质瘤细胞中,与放疗联合使用时,Au-OMV使细胞内活性氧(ROS)大幅增加。此外,通过G261胶质瘤细胞与RAW 264.7巨噬细胞的共培养,我们发现GL261细胞活力与巨噬细胞的趋化性和TNF-α的产生有关。